Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

The HLA-B Leader MM Genotype Has a Negative Impact on Outcomes in HLA-B One Antigen Mismatched and HLA-B Matched Cord Blood Transplantation without Anti-Thymocyte Globulin: Analysis of the Japanese Society for Transplantation and Cellular Therapy

Blood (2023) 142 (Supplement 1): 1048.

https://doi.org/10.1182/blood-2023-178905

Published: 2023

Journal Articles

Comparison of Non-Relapse Mortality after Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide Versus Single Umbilical Cord Blood Transplantation for Hematologic Disease

Kaito Harada, Junya Kanda, Masahiro Hirayama, Fumiya Wada, Naoyuki Uchida, Hirohisa Nakamae, Masatsugu Tanaka, Makoto Onizuka, Hiroyuki Ohigashi, Nobuaki Nakano, Takahiro Fukuda, Kazuya Ishiwata, Yumiko Maruyama, Tetsuya Eto, Fumihiko Ishimaru, Yoshiko Atsuta, Hideki Nakasone, Takashi Tanaka

Blood (2023) 142 (Supplement 1): 4905.

https://doi.org/10.1182/blood-2023-184821

Published: 2023

Journal Articles

HLA-B Leader Dimorphism Impacts on Outcomes of HLA-Matched Related/Unrelated Transplantation: Analysis of the Japanese Society for Transplantation and Cellular Therapy

Minoru Kanaya, Yasuo Morishima, Nobuyoshi Arima, Masahiro Hirayama, Souichi Shiratori, Noriko Doki, Yukiyasu Ozawa, Takahiro Fukuda, Masatsugu Tanaka, Masashi Sawa, Satoru Takada, Shuichi Ota, Toshiro Kawakita, Junya Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Satoko Morishima

Blood (2021) 138 (Supplement 1): 2919.

https://doi.org/10.1182/blood-2021-144669

Published: 2021

Journal Articles

A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trial

Blood (2020) 136 (16): 1813–1823.

https://doi.org/10.1182/blood.2019004741

Published: 2020

Includes: Supplemental data

Journal Articles

Difference in the Donor Selection Priority in Allogeneic Hematopoietic Stem Cell Transplantation According to Patient Age

Koji Kawamura, Junya Kanda, MD, Sachiko Seo, MDPhD, Fumihiko Kimura, MD PhD, Masahiro Hirayama, MD PhD, Naoyuki Uchida, MD PhD, Noriko Doki, MD PhD, Takahiro Fukuda, Yukiyasu Ozawa, MD PhD, Yuta Katayama, MD PhD, Minoko Takanashi, MD PhD, Yoshiko Atsuta, MD PhD, Yoshinobu Kanda, MD PhD

Blood (2019) 134 (Supplement_1): 46.

https://doi.org/10.1182/blood-2019-125032

Published: 2019

Journal Articles

Intensive Chemotherapy Along with Aggressive Supportive Care Can Spare Stem Cell Transplantation in a Subset of Patients without Compromising an Outcome in Infants with Acute Lymphoblastic Leukemia; A Report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) Trial MLL-10

Blood (2019) 134 (Supplement_1): 2626.

https://doi.org/10.1182/blood-2019-121328

Published: 2019

Journal Articles

Individual Pharmacokinetic Targeting of Busulfan in Allogeneic Hematopoietic Stem Cell Transplantation Is Essential for Infants with MLL Gene-Rearranged Acute Lymphoblastic Leukemia: A Report from the JPLSG MLL03 Study

Takayuki Takachi, MD PhD, Yuki Arakawa, MD, Hiroyoshi Nakamura, PhD, Tomoyuki Watanabe, PhD, Yuki Aoki, MD PhD, Junjiro Ohshima, MD PhD, Yoshihiro Takahashi, MD PhD, Masahiro Hirayama, MD PhD, Takako Miyamura, MD PhD, Kanji Sugita, MD PhD, Katsuyoshi Koh, MD PhD, Keizo Horibe, MD PhD, Eiichi Ishii, MD PhD, Daisuke Tomizawa, MD PhD

Blood (2015) 126 (23): 1915.

https://doi.org/10.1182/blood.V126.23.1915.1915

Published: 2015

Journal Articles

Effect of KIR Ligand Mismatched SCT for Infantile ALL with MLL gene Rearrangement: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)

Takako Miyamura, MD, PhD, Masahiro Hirayama, MD, PhD, Kanji Sugita, MD, PhD, Tomoyuki Watanabe, PhD, Eiichi Ishii, MD, PhD, Katsuyoshi Koh, MD, PhD, Koji Kato, MD, PhD, Akiko Moriya Saito, MD, PhD, Keizo Horibe, MD, Masahito Tsurusawa, MD, PhD, Daisuke Tomizawa

Blood (2012) 120 (21): 4543.

https://doi.org/10.1182/blood.V120.21.4543.4543

Published: 2012

Journal Articles

Early Phase Administration of Hematopoietic Stem Cell Transplantation to Prevent Early Relapse for Infants with Acute Lymphoblastic Leukemia and MLL Gene Rearrangement; a Report From the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) Trial MLL03

Katsuyoshi Koh, MD, Daisuke Tomizawa, MD, Akiko Moriya Saito, MD, PhD, Tomoyuki Watanabe, PhD, Atsushi Ogawa, MD, Takashi Sato, MD, Masahiro Hirayama, MD, Yoshihiro Takahashi, MD, Yutaka Saikawa, MD, PhD, Takako Miyamura, MD, Koji Kato, MD, PhD, Kanji Sugita, MD, PhD, Takeyuki Sato, MD, Tomohiko Taki, MD, PhD, Shuki Mizutani, MD, PhD, Masahito Tsurusawa, MD, Keizo Horibe, MD, Eiichi Ishii, MD, PhD

Blood (2010) 116 (21): 529.

https://doi.org/10.1182/blood.V116.21.529.529

Published: 2010

Journal Articles

Nation-Wide Survey of Relapsed Infantile Acute Lymphoblastic Leukemia In Japan: Treatment and Outcome From the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) MLL03 Study.

Takako Miyamura, MD, PhD, Katsuyoshi Koh, MD, Daisuke Tomizawa, MD, Takashi Sato, MD, PhD, Koji Kato, MD, PhD, Kanji Sugita, MD, PhD, Masahiro Hirayama, MD, Atsushi Ogawa, MD, Yoshihiro Takahashi, MD, Ryosei Nishimura, MD, PhD, Hidemasa Ochiai, MD, Yuko Nomura, MD, Akiko Saito, MD, PhD, Masahito Tsurusawa, MD, PhD, Keizo Horibe, MD, PhD, Eiichi Ishii, MD, PhD

Blood (2010) 116 (21): 1025.

https://doi.org/10.1182/blood.V116.21.1025.1025

Published: 2010

Journal Articles

Nation-Wide Survey of Infant Leukemia in Japan: A Report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG).

Takako Miyamura, MD. PhD, Katsuyoshi Koh, MD. PhD, Daisuke Tomizawa, MD, Kanji Sugita, MD. PhD, Koji Kato, MD. PhD, Takashi Sato, MD. PhD, Yoshihiro Takahashi, MD. PhD, Atsushi Ogawa, MD. PhD, Masahiro Hirayama, MD. PhD, Akira Kikuchi, MD. PhD, Megumi Oda, MD. PhD, Daiichiro Hasegawa, MD. PhD, Kazutoshi Koike, MD. PhD, Yutaka Saikawa, MD. PhD, Michiki Hatanaka, MD. PhD, Keizo Horibe, MD. PhD, Eiichi Ishii, MD. PhD

Blood (2008) 112 (11): 896.

https://doi.org/10.1182/blood.V112.11.896.896

Published: 2008

Journal Articles

Engraftment Rate and Kinetics Following Umbilical Cord Blood Transplantation Is Critically Affected by CD34 + Progenitor Cell Dose and CD8 + T-Cell Dose Complementary.

Seitaro Terakura, MD,PhD, Eiichi Azuma, MD,PhD, Makoto Murata, MD,PhD, Tadashi Kumamoto, MD,PhD, Masahiro Hirayama, MD,PhD, Makoto Yazaki, MD,PhD, Tomoki Naoe, MD,PhD, Koji Kato, MD,PhD

Blood (2006) 108 (11): 5396.

https://doi.org/10.1182/blood.V108.11.5396.5396

Published: 2006

Journal Articles

Development of Dendritic Cell Vaccine Against Measles for Patients Following Hematopoietic Cell Transplantation.

Tadashi Kumamoto, MD, PhD, Yuji Nashida, MD, Masahiro Hirayama, MD, PhD, Eiichi Azuma, MD, PhD, Yoshihiro Komada, MD, PhD

Blood (2005) 106 (11): 476.

https://doi.org/10.1182/blood.V106.11.476.476

Published: 2005

NARROW

The HLA-B Leader MM Genotype Has a Negative Impact on Outcomes in HLA-B One Antigen Mismatched and HLA-B Matched Cord Blood Transplantation without Anti-Thymocyte Globulin: Analysis of the Japanese Society for Transplantation and Cellular Therapy

Comparison of Non-Relapse Mortality after Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide Versus Single Umbilical Cord Blood Transplantation for Hematologic Disease

HLA-B Leader Dimorphism Impacts on Outcomes of HLA-Matched Related/Unrelated Transplantation: Analysis of the Japanese Society for Transplantation and Cellular Therapy

A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trial

Difference in the Donor Selection Priority in Allogeneic Hematopoietic Stem Cell Transplantation According to Patient Age

Intensive Chemotherapy Along with Aggressive Supportive Care Can Spare Stem Cell Transplantation in a Subset of Patients without Compromising an Outcome in Infants with Acute Lymphoblastic Leukemia; A Report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) Trial MLL-10

Individual Pharmacokinetic Targeting of Busulfan in Allogeneic Hematopoietic Stem Cell Transplantation Is Essential for Infants with MLL Gene-Rearranged Acute Lymphoblastic Leukemia: A Report from the JPLSG MLL03 Study

Effect of KIR Ligand Mismatched SCT for Infantile ALL with MLL gene Rearrangement: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)

Early Phase Administration of Hematopoietic Stem Cell Transplantation to Prevent Early Relapse for Infants with Acute Lymphoblastic Leukemia and MLL Gene Rearrangement; a Report From the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) Trial MLL03

Nation-Wide Survey of Relapsed Infantile Acute Lymphoblastic Leukemia In Japan: Treatment and Outcome From the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) MLL03 Study.

Nation-Wide Survey of Infant Leukemia in Japan: A Report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG).

Engraftment Rate and Kinetics Following Umbilical Cord Blood Transplantation Is Critically Affected by CD34 + Progenitor Cell Dose and CD8 + T-Cell Dose Complementary.

Development of Dendritic Cell Vaccine Against Measles for Patients Following Hematopoietic Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only